300813 泰林生物
已收盘 09-11 15:00:00
资讯
新帖
简况
股市必读：泰林生物新发布《2026年半年度报告》
证券之星 · 08-28
股市必读：泰林生物新发布《2026年半年度报告》
泰林生物（300813）2026年中报简析：营收净利润同比双双增长，公司应收账款体量较大
证券之星 · 08-28
泰林生物（300813）2026年中报简析：营收净利润同比双双增长，公司应收账款体量较大
股市必读：泰林生物中报 - 第二季度单季净利润同比增长55.10%
证券之星 · 08-27
股市必读：泰林生物中报 - 第二季度单季净利润同比增长55.10%
泰林生物(300813)6月30日股东户数1.09万户，较上期减少30.1%
证券之星 · 08-26
泰林生物(300813)6月30日股东户数1.09万户，较上期减少30.1%
泰林生物(300813.SZ)发布上半年业绩，归母净利润2037.28万元，同比增长50.43%
智通财经 · 08-26
泰林生物(300813.SZ)发布上半年业绩，归母净利润2037.28万元，同比增长50.43%
泰林生物终止发不超2.3亿可转债 为长城证券保荐项目
中金财经 · 08-17
泰林生物终止发不超2.3亿可转债 为长城证券保荐项目
股市必读：泰林生物新发布《关于终止向不特定对象发行可转换公司债券并撤回申请文件的公告》
证券之星 · 08-17
股市必读：泰林生物新发布《关于终止向不特定对象发行可转换公司债券并撤回申请文件的公告》
股市必读：泰林生物新发布《关于取得专利证书的公告》
证券之星 · 08-10
股市必读：泰林生物新发布《关于取得专利证书的公告》
泰林生物（300813）披露取得发明专利证书公告，8月7日股价上涨2.57%
证券之星 · 08-07
泰林生物（300813）披露取得发明专利证书公告，8月7日股价上涨2.57%
股市必读：泰林生物（300813）新发布《关于取得专利证书及计算机软件著作权登记证书的公告》
证券之星 · 07-31
股市必读：泰林生物（300813）新发布《关于取得专利证书及计算机软件著作权登记证书的公告》
股市必读：泰林生物（300813）7月14日董秘有最新回复
证券之星 · 07-15
股市必读：泰林生物（300813）7月14日董秘有最新回复
泰林生物：TOC总有机碳分析仪可应用于超纯水
证券之星 · 07-14
泰林生物：TOC总有机碳分析仪可应用于超纯水
泰林生物不超2.3亿元可转债被暂缓审议 长城证券保荐
中金财经 · 07-14
泰林生物不超2.3亿元可转债被暂缓审议 长城证券保荐
泰林生物（300813）披露独立董事取得独立董事培训证明的公告，7月6日股价上涨4.39%
证券之星 · 07-06
泰林生物（300813）披露独立董事取得独立董事培训证明的公告，7月6日股价上涨4.39%
泰林生物（300813）披露向不特定对象发行可转换公司债券募集说明书（上会稿），7月3日股价上涨2.81%
证券之星 · 07-03
泰林生物（300813）披露向不特定对象发行可转换公司债券募集说明书（上会稿），7月3日股价上涨2.81%
股市必读：新发布《浙江泰林生物技术股份有限公司与长城证券股份有限公司关于浙江泰林生物技术股份有限公司向不特定对象发行可转换公司债券的审核问询函之回复报告》
证券之星 · 07-02
股市必读：新发布《浙江泰林生物技术股份有限公司与长城证券股份有限公司关于浙江泰林生物技术股份有限公司向不特定对象发行可转换公司债券的审核问询函之回复报告》
泰林生物（300813）披露2026年第一次临时股东会决议公告，6月2日股价下跌1.6%
证券之星 · 06-02
泰林生物（300813）披露2026年第一次临时股东会决议公告，6月2日股价下跌1.6%
股市必读：泰林生物（300813）5月18日董秘有最新回复
证券之星 · 05-19
股市必读：泰林生物（300813）5月18日董秘有最新回复
泰林生物：公司生产的硝酸纤维素膜可以于免疫层析诊断试剂中用作C/T线的承载体
证券之星 · 05-18
泰林生物：公司生产的硝酸纤维素膜可以于免疫层析诊断试剂中用作C/T线的承载体
每周股票复盘：泰林生物（300813）股东户数增42.43%，净利升37.19%
证券之星 · 05-03
每周股票复盘：泰林生物（300813）股东户数增42.43%，净利升37.19%
加载更多
公司概况
公司名称：
浙江泰林生物技术股份有限公司
所属行业：
专用设备制造业
上市日期：
2020-01-14
主营业务：
浙江泰林生物技术股份有限公司的主营业务是无菌生产与污染控制设备、微生物检测及有机物分析等产品的研发、生产和销售。公司的主要产品是无菌生产与污染控制设备系列产品、微生物检测技术系列产品、有机物分析技术系列产品。
发行价格：
18.35
{"stockData":{"symbol":"300813","market":"SZ","secType":"STK","nameCN":"泰林生物","latestPrice":20.3,"timestamp":1789110216000,"preClose":20.44,"halted":0,"volume":2355100,"delay":0,"changeRate":-0.0068,"floatShares":85126100,"shares":121000000,"eps":0.1924,"marketStatus":"已收盘","change":-0.14,"latestTime":"09-11 15:00:00","open":20.3,"high":20.4,"low":19.53,"amount":46888500,"amplitude":0.0426,"askPrice":20.3,"askSize":50,"bidPrice":20.29,"bidSize":6,"shortable":0,"etf":0,"ttmEps":0.1924,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":5,"adr":0,"adjPreClose":20.44,"symbolType":"stock","openAndCloseTimeList":[[1789090200000,1789097400000],[1789102800000,1789110000000]],"highLimit":22.48,"lowLimit":18.4,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":121199219,"isCdr":false,"pbRate":3.13,"roa":"--","peRate":105.509356,"roe":"2.53%","epsLYR":0.14,"committee":-0.805226,"marketValue":2460000000,"turnoverRate":0.0277,"status":1,"floatMarketCap":1728000000},"requestUrl":"/m/hq/s/300813","defaultTab":"news","newsList":[{"id":"2662031101","title":"股市必读：泰林生物新发布《2026年半年度报告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662031101","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662031101?lang=zh_cn&edition=full","pubTime":"2026-08-28 07:32","pubTimestamp":1787873535,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，泰林生物报收于21.43元，上涨4.54%，换手率6.36%，成交量5.41万手，成交额1.16亿元。公司公告汇总：2026年半年度营业收入同比增长13.41%，归母净利润同比增长50.43%，经营性现金流同比大增576.15%。该方案尚需提交2026年第二次临时股东大会审议。关于2026年半年度报告披露的提示性公告2026年半年度报告已于2026年8月27日在巨潮资讯网披露。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800013857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039279","title":"泰林生物（300813）2026年中报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039279","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662039279?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:46","pubTimestamp":1787870781,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期泰林生物发布2026年中报。截至本报告期末，公司营业总收入1.65亿元，同比上升13.41%，归母净利润2037.28万元，同比上升50.43%。本报告期泰林生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达336.31%。去年的净利率为4.8%，算上全部成本后，公司产品或服务的附加值不高。财报体检工具显示：建议关注公司应收账款状况本文数据来源于泰林生物2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800013173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662289367","title":"股市必读：泰林生物中报 - 第二季度单季净利润同比增长55.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662289367","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662289367?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:43","pubTimestamp":1787784184,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘，泰林生物报收于20.5元，下跌1.2%，换手率3.39%，成交量2.58万手，成交额5384.36万元。股本股东变化：截至2026年6月30日股东户数为1.09万户，较3月31日减少30.1%，户均持股增至1.12万股。业绩披露要点：2026年第二季度单季度归母净利润1553.25万元，同比上升55.1%。关于2026年半年度报告披露的提示性公告2026年半年度报告已于2026年8月27日在巨潮资讯网披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700013115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662792823","title":"泰林生物(300813)6月30日股东户数1.09万户，较上期减少30.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662792823","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662792823?lang=zh_cn&edition=full","pubTime":"2026-08-26 17:48","pubTimestamp":1787737702,"startTime":"0","endTime":"0","summary":"证券之星消息，近日泰林生物披露，截至2026年6月30日公司股东户数为1.09万户，较3月31日减少4674.0户，减幅为30.1%。在专用设备行业个股中，泰林生物股东户数低于行业平均水平，截至6月30日，专用设备行业平均股东户数为2.94万户。从股价来看，2026年3月31日至2026年6月30日，泰林生物区间跌幅为34.03%，在此期间股东户数减少4674.0户，减幅为30.1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600040317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662799591","title":"泰林生物(300813.SZ)发布上半年业绩，归母净利润2037.28万元，同比增长50.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662799591","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662799591?lang=zh_cn&edition=full","pubTime":"2026-08-26 16:45","pubTimestamp":1787733934,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰林生物(300813.SZ)发布2026年半年度报告，报告期内，公司实现营业收入1.65亿元，同比增长13.41%。实现归属于上市公司股东的净利润2037.28万元，同比增长50.43%。实现归属于上市公司股东的扣除非经常性损益的净利润1825.2万元，同比增长38.23%。拟向全体股东每10股派发现金红利1元(含税)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485976.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"泰林生物(300813.SZ)发布上半年业绩，归母净利润2037.28万元，同比增长50.43%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660101211","title":"泰林生物终止发不超2.3亿可转债 为长城证券保荐项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2660101211","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660101211?lang=zh_cn&edition=full","pubTime":"2026-08-17 11:33","pubTimestamp":1786937589,"startTime":"0","endTime":"0","summary":"中国经济网北京8月17日讯 泰林生物 披露公告，公司于2026年8月14日召开第四届董事会第十五次会议，审议通过了《关于终止向不特定对象发行可转换公司债券并撤回申请文件的议案》，同意公司终止本次向不特定对象发行可转换公司债券并向深圳证券交易所申请撤回相关申请文件。 泰林生物表示，公司2025年度股东会已授权董事会全权办理本次发行可转换公司债券的全部事宜，本议案无需提交股东会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260817/32336724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300813","002939","BK0276","BK0251","SABA","FCEF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660705921","title":"股市必读：泰林生物新发布《关于终止向不特定对象发行可转换公司债券并撤回申请文件的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660705921","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660705921?lang=zh_cn&edition=full","pubTime":"2026-08-17 01:44","pubTimestamp":1786902254,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，泰林生物报收于20.48元，上涨1.14%，换手率6.7%，成交量5.1万手，成交额1.07亿元。公司公告汇总关于终止向不特定对象发行可转换公司债券并撤回申请文件的公告浙江泰林生物技术股份有限公司于2026年8月14日召开第四届董事会第十五次会议，审议通过终止向不特定对象发行可转换公司债券并撤回申请文件的议案。公司综合考虑实际情况和发展规划等因素，经与相关各方沟通后决定终止可转债发行并撤回申请文件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700000624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658608150","title":"股市必读：泰林生物新发布《关于取得专利证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658608150","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658608150?lang=zh_cn&edition=full","pubTime":"2026-08-10 03:02","pubTimestamp":1786302135,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，泰林生物报收于19.98元，上涨2.57%，换手率2.81%，成交量2.14万手，成交额4186.4万元。当日关注点交易信息汇总：8月7日主力资金净流入58.0万元，占总成交额1.39%。公司公告汇总：全资子公司泰林医学工程取得一项放射性药物高精度自动混合分装装置发明专利，授权公告日为2026年8月4日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000001310.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657364280","title":"泰林生物（300813）披露取得发明专利证书公告，8月7日股价上涨2.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657364280","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657364280?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:40","pubTimestamp":1786113628,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，泰林生物报收于19.98元，较前一交易日上涨2.57%，最新总市值为24.22亿元。该股当日开盘19.42元，最高20.0元，最低19.12元，成交额达4186.4万元，换手率为2.81%。近日，浙江泰林生物技术股份有限公司全资子公司浙江泰林医学工程有限公司取得1项发明专利证书，专利名称为一种放射性药物的高精度自动混合分装装置及其分装方法，专利类型为发明，申请号2023118192043，授权公告日2026年8月4日，专利权人为泰林医学工程。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700041563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655800701","title":"股市必读：泰林生物（300813）新发布《关于取得专利证书及计算机软件著作权登记证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2655800701","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655800701?lang=zh_cn&edition=full","pubTime":"2026-07-31 02:56","pubTimestamp":1785437773,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘，泰林生物报收于17.79元，下跌2.25%，换手率2.55%，成交量1.94万手，成交额3515.75万元。公司公告汇总关于取得专利证书及计算机软件著作权登记证书的公告浙江泰林生物技术股份有限公司全资子公司泰林生命科学取得2项发明专利和1项实用新型专利，泰林医学工程取得1项计算机软件著作权登记证书。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100002000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651748555","title":"股市必读：泰林生物（300813）7月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2651748555","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651748555?lang=zh_cn&edition=full","pubTime":"2026-07-15 02:32","pubTimestamp":1784053930,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，泰林生物报收于20.71元，下跌3.63%，换手率4.92%，成交量3.74万手，成交额7752.85万元。当日关注点交易信息汇总：7月14日主力资金净流出445.6万元，散户资金净流入1122.17万元。公司公告汇总：泰林生物全资子公司近期取得2项专利证书，含1项发明专利和1项实用新型专利，授权公告日均为2026年6月23日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500002827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651203691","title":"泰林生物：TOC总有机碳分析仪可应用于超纯水","url":"https://stock-news.laohu8.com/highlight/detail?id=2651203691","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651203691?lang=zh_cn&edition=full","pubTime":"2026-07-14 15:09","pubTimestamp":1784012954,"startTime":"0","endTime":"0","summary":"证券之星消息，泰林生物(300813)07月14日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在半导体级超纯水质检测有哪些应用与产品？泰林生物回复：您好，公司有机物分析系列的TOC总有机碳分析仪可应用于超纯水、制药用水、天然水体、饮用水、环保污水、化工工艺用水的水质分析与检测，其中超纯水方面的应用主要是超纯水的生产环节、废水回用前的检测环节。公司有机物分析系列产品目前主要还是应用于制药用水等领域，在公司整体营收中占比低于10%，在超纯水方面的应用占整体营收的比重低于1%，对公司经营业绩影响不大。谢谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400022809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651127156","title":"泰林生物不超2.3亿元可转债被暂缓审议 长城证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2651127156","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651127156?lang=zh_cn&edition=full","pubTime":"2026-07-14 14:48","pubTimestamp":1784011686,"startTime":"0","endTime":"0","summary":"中国经济网北京7月14日讯 深交所上市审核委员会2026 年第42 次审议会议于昨日召开，审议结果显示，浙江泰林生物技术股份有限公司 向不特定对象发行可转债暂缓审议。 泰林生物本次的保荐机构为长城证券股份有限公司，保荐代表人严绍东、白毅敏。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202607/14/20260714489719.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202607/14/20260714489719.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260714/32306808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0276","SABA","BK0251","002939","300813","FCEF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649400016","title":"泰林生物（300813）披露独立董事取得独立董事培训证明的公告，7月6日股价上涨4.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649400016","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649400016?lang=zh_cn&edition=full","pubTime":"2026-07-06 17:44","pubTimestamp":1783331042,"startTime":"0","endTime":"0","summary":"近日，浙江泰林生物技术股份有限公司发布公告称：公司于2026年5月15日召开第四届董事会第十三次会议，2026年6月1日召开2026年第一次临时股东会，审议通过补选叶树明为第四届董事会独立董事的议案。叶树明先生此前尚未取得独立董事培训证明，已承诺参加最近一次培训。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600025215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648503106","title":"泰林生物（300813）披露向不特定对象发行可转换公司债券募集说明书（上会稿），7月3日股价上涨2.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648503106","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648503106?lang=zh_cn&edition=full","pubTime":"2026-07-03 17:38","pubTimestamp":1783071536,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，泰林生物报收于20.52元，较前一交易日上涨2.81%，最新总市值为24.87亿元。该股当日开盘20.15元，最高21.08元，最低20.15元，成交额达5825.21万元，换手率为3.72%。公告显示，公司拟向不特定对象发行可转换公司债券，募集资金总额不超过23,000万元，用于高性能过滤器及配套功能膜产业化项目和补充流动资金。本次发行未提供担保。报告期内经营业绩存在波动，2023年至2025年净利润分别为1,966.90万元、1,305.07万元和1,648.54万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300032637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648529399","title":"股市必读：新发布《浙江泰林生物技术股份有限公司与长城证券股份有限公司关于浙江泰林生物技术股份有限公司向不特定对象发行可转换公司债券的审核问询函之回复报告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2648529399","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648529399?lang=zh_cn&edition=full","pubTime":"2026-07-02 04:41","pubTimestamp":1782938469,"startTime":"0","endTime":"0","summary":"浙江泰林生物技术股份有限公司与长城证券股份有限公司关于浙江泰林生物技术股份有限公司向不特定对象发行可转换公司债券的审核问询函之回复报告公司就审核问询函进行回复，涉及营业收入、净利润、毛利率、政府补助、应收账款、存货、产能利用率、行政处罚及财务性投资等事项的说明与核查；保荐人长城证券及其他中介机构确认公司符合发行条件，相关信息披露真实、准确、完整。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200002109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002939","BK0276","BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640914907","title":"泰林生物（300813）披露2026年第一次临时股东会决议公告，6月2日股价下跌1.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640914907","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640914907?lang=zh_cn&edition=full","pubTime":"2026-06-02 18:16","pubTimestamp":1780395406,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，泰林生物报收于21.55元，较前一交易日下跌1.6%，最新总市值为26.12亿元。公司于近日发布《2026年第一次临时股东会决议公告》。公告显示，浙江泰林生物技术股份有限公司于2026年6月1日召开2026年第一次临时股东会，会议由董事会召集，董事长叶大林主持，出席会议的股东共65人，代表股份53,839,464股，占公司有表决权股份总数的44.4223%。中小股东对该议案的同意股份数占其有效表决权股份总数的72.8265%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200036566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636003994","title":"股市必读：泰林生物（300813）5月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2636003994","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636003994?lang=zh_cn&edition=full","pubTime":"2026-05-19 01:58","pubTimestamp":1779127093,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘，泰林生物报收于24.25元，下跌1.38%，换手率2.49%，成交量1.89万手，成交额4590.78万元。董秘最新回复投资者： 公司能检测汉坦病毒吗?当日关注点来自交易信息汇总：5月18日主力资金净流出394.55万元，散户资金净流入564.14万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900002205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636040035","title":"泰林生物：公司生产的硝酸纤维素膜可以于免疫层析诊断试剂中用作C/T线的承载体","url":"https://stock-news.laohu8.com/highlight/detail?id=2636040035","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636040035?lang=zh_cn&edition=full","pubTime":"2026-05-18 15:30","pubTimestamp":1779089455,"startTime":"0","endTime":"0","summary":"证券之星消息，泰林生物(300813)05月18日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的NC膜系列产品，可作为检测汉坦病毒检测技术的诊断试剂盒的生产原料吗?泰林生物回复：您好，公司生产的硝酸纤维素膜（简称NC膜）可以于免疫层析诊断试剂中用作C/T线的承载体，同时也是免疫反应的发生处，是免疫层析诊断试剂盒生产的原材料之一。谢谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800016100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632813677","title":"每周股票复盘：泰林生物（300813）股东户数增42.43%，净利升37.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632813677","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632813677?lang=zh_cn&edition=full","pubTime":"2026-05-03 05:12","pubTimestamp":1777756336,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，泰林生物报收于25.63元，较上周的24.96元上涨2.68%。本周，泰林生物4月27日盘中最高价报26.23元。泰林生物当前最新总市值31.06亿元，在专用设备板块市值排名146/178，在两市A股市值排名4584/5200。本周关注点股本股东变化：股东户数较上期增加42.43%，户均持股下降至7806.0股。业绩披露要点：归母净利润484.03万元，同比上升37.19%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789299742558,"stockEarnings":[{"period":"1week","weight":-0.0122},{"period":"1month","weight":-0.0078},{"period":"3month","weight":0.0074},{"period":"6month","weight":-0.2113},{"period":"1year","weight":-0.354},{"period":"ytd","weight":-0.1728}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江泰林生物技术股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"10852人(较上一季度减少30.10%)","perCapita":"7844股","listingDate":"2020-01-14","address":"浙江省杭州市滨江区南环路2930号","registeredCapital":"12119万元","survey":" 浙江泰林生物技术股份有限公司的主营业务是无菌生产与污染控制设备、微生物检测及有机物分析等产品的研发、生产和销售。公司的主要产品是无菌生产与污染控制设备系列产品、微生物检测技术系列产品、有机物分析技术系列产品。","listedPrice":18.35},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰林生物(300813)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰林生物(300813)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰林生物,300813,泰林生物股票,泰林生物股票老虎,泰林生物股票老虎国际,泰林生物行情,泰林生物股票行情,泰林生物股价,泰林生物股市,泰林生物股票价格,泰林生物股票交易,泰林生物股票购买,泰林生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰林生物(300813)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰林生物(300813)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}